Announcements Trials
Browse Landscape

Phase

Phase NA 4

Status

Active not recruiting 2Terminated 1Recruiting 1

Sponsor Class

OTHER 4

Study Type

Interventional 4

Sponsor

Cancer Type

Breast 15Gynecologic 4Gastrointestinal 4CNS 2Head & Neck 1

Conditions

Ovarian Neoplasms 5Endometrial Neoplasms 5Colorectal Neoplasms 4Breast Neoplasms 4Colorectal Neoplasms, Hereditary Nonpolyposis 3Hereditary Breast and Ovarian Cancer Syndrome 2Colonic Neoplasms 2Urogenital Neoplasms 1Rectal Neoplasms 1Prostatic Neoplasms 1Primary Ovarian Insufficiency 1Pancreatic Neoplasms 1Neoplastic Syndromes, Hereditary 1Endometrial Hyperplasia 1Carcinoma, Intraductal, Noninfiltrating 1Brain Neoplasms 1

Interventions

pembrolizumab 33Paclitaxel 27Cyclophosphamide 25Carboplatin 23olaparib 21Fulvestrant 15fludarabine 14Trastuzumab 14aldesleukin 13Docetaxel 13Early Intervention, Educational 12Surveys and Questionnaires 11veliparib 10palbociclib 10Methods 10Gemcitabine 10Blood Specimen Collection 10Nivolumab 9Flow Cytometry 9Biopsy 9Bevacizumab 9sargramostim 8niraparib 7liposomal doxorubicin 7Therapeutics 7Taxes 7Standard of Care 7Psychiatric Rehabilitation 7Magnetic Resonance Spectroscopy 7talazoparib 6

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Breast Neoplasms × Genetic Testing × Gynecologic × Clear all
NCT05649072 2026-05-22

Identifying Underserved Individuals inTexas With Hereditary Cancer Risk Using Mobile Mammography Units and Telegenetics.

M.D. Anderson Cancer Center

Phase NA Recruiting
1,000 enrolled
BreastGastrointestinalGynecologic

Breast Neoplasms, Ovarian Neoplasms, Colorectal Neoplasms

NCT02664389 2026-05-06

PANEL

University Hospital, Rouen

Phase NA Terminated
289 enrolled
BreastGastrointestinalGynecologic

Breast Neoplasms, Ovarian Neoplasms, Colorectal Neoplasms

NCT03731845 2025-11-20

ESIGON

Assistance Publique - Hôpitaux de Paris

Phase NA Active not recruiting
73 enrolled
BreastGynecologic

Breast Neoplasms, Primary Ovarian Insufficiency

NCT03246841 2024-12-12

TUMOSPEC

UNICANCER

Phase NA Active not recruiting
7,274 enrolled
BreastGynecologic

Breast Neoplasms, Ovarian Neoplasms, Hereditary Breast and Ovarian Cancer Syndrome

Data powered by HemOnc (CC BY 4.0) Colophon âš¡